Datavant, a portfolio company of New Mountain Capital, announced that it will acquire New York City-based Aetion. The two companies will leverage their capabilities to create an end-to-end offering on data discovery, linkage, privacy, curation and advanced analysis, allowing their ecosystem and life sciences partners to create analytics-based insights.
Founded in 2013, Aetion is focused on real-world evidence (RWE) in healthcare. Aetion provides RWE offerings to biopharmaceutical companies, medical device manufacturers, payers and regulators.
Datavant is a health information technology company based in Phoenix, Arizona. The company develops and maintains a digital ecosystem for the exchange of healthcare data. Davavant’s platform enables healthcare records to move between organizations, including more than 70,000 hospitals and clinics.
According to the two companies, Aetion will increase the Datavant Connect platform’s data discovery features, strengthen privacy assessments and give customers datasets and analytics. In addition, the Aetion Evidence Platform will be available in Amazon Web Services’ Marketplace. Financial terms of the deal were not disclosed.
According to data in the LevinPro HC database, this transaction represents the 120th eHealth acquisition of 2025, and the 15th in the analytics specialty. Analytics is the fifth most active eHealth subsector so far this year, behind medical practice management software (16 deals), revenue cycle management (21 deals), telehealth (21 deals) and patient engagement (23 deals). There were 30 analytics transactions reported in 2024, and 35 reported in 2023.
